Beta-Blockers or ARBs for Marfan?

When it comes to protecting your heart and slowing the enlargement (dilation) of the aorta in Marfan syndrome, current medical consensus shows that both beta-blockers and angiotensin receptor blockers (ARBs, like Losartan) are highly effective first-line treatments ^[1][2]. Large clinical trials have demonstrated that neither drug is clearly superior to the other; they both do an excellent job of reducing the stress on your aortic wall ^[1][3]. The “better” choice depends entirely on how your body tolerates the medication, your family planning goals, and whether you have other health conditions.

How Do They Work?

Though both medications protect the aorta, they achieve this goal in completely different ways:

• Beta-blockers (such as atenolol or metoprolol) work by lowering your heart rate and reducing the physical force of each heartbeat ^[4]. By softening the impact of blood pumping out of the heart, they decrease the mechanical stress on the fragile aortic wall ^[5].
• ARBs (such as Losartan or Irbesartan) were originally designed to lower blood pressure, but they also have a unique benefit for Marfan syndrome. They block a specific chemical pathway in the body called TGF-beta ^[6]. In Marfan syndrome, the TGF-beta pathway is overactive and contributes to the weakening of the connective tissue in the aorta ^[7]. ARBs help quiet this pathway down, structurally protecting the aortic wall ^[8].

Are They Used Together?

Yes, they often are. Because these drugs protect the aorta through entirely different mechanisms, many specialists prescribe them together ^[9]. Recent research suggests that combining a beta-blocker with an ARB can provide an “additive benefit,” slowing aortic root dilation even more than either medication used alone ^[10][11]. If your blood pressure can tolerate both medications without dropping too low, your cardiologist might recommend this combination approach.

Choosing What is Right for You

Because beta-blockers and ARBs are equally effective at protecting the aorta ^[1], the decision usually comes down to side effects and your individual lifestyle. It is common to experience some dizziness in the first few weeks of taking either medication as your body adjusts to a lower blood pressure.

Considerations for Beta-blockers:

• Fatigue and Sluggishness: Beta-blockers can make you feel tired or sluggish. You may notice this fatigue most during physical activity, even while following the modified, low-intensity exercise guidelines recommended for Marfan syndrome.
• Asthma: If you have asthma, beta-blockers are used with extreme caution because they can trigger symptoms. Your doctor might choose a “cardioselective” beta-blocker (like metoprolol) under close supervision, or avoid them altogether.

Considerations for ARBs (Losartan):

• Pregnancy: ARBs are strictly unsafe during pregnancy because they can cause severe harm to a developing baby. If you are pregnant or actively trying to conceive, your doctor will likely switch you to a beta-blocker that is considered safer during pregnancy, though you will still require careful monitoring by a high-risk obstetrician. Note that some specific beta-blockers, like atenolol, are also generally avoided during pregnancy.
• Daily Side Effects: While many patients find ARBs easier to tolerate than beta-blockers without the associated fatigue, they can cause dizziness (especially when standing up quickly) and occasionally impact kidney function. Your doctor will likely order routine blood tests to monitor your kidneys.

Finally, remember that while these medications are highly effective at slowing dilation, they do not replace the need for lifelong medical surveillance ^[12]. Your care team will continue to track your progress using regular echocardiograms or MRIs to ensure your aorta remains stable. You will work together to find the medication strategy that best protects your heart while allowing you to feel your best.